|
Volumn 34, Issue 5, 2002, Pages 1646-1648
|
A cost-effectiveness analysis of tacrolimus versus cyclosporine microemulsion following kidney transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
TACROLIMUS;
CYCLOSPORIN;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFECT;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEALTH CARE COST;
HEALTH ECONOMICS;
HOSPITALIZATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ARTICLE;
COST;
COST BENEFIT ANALYSIS;
ECONOMICS;
EMULSION;
GERMANY;
IMMUNOLOGY;
MORTALITY;
SURVIVAL;
COST-BENEFIT ANALYSIS;
COSTS AND COST ANALYSIS;
CYCLOSPORINE;
EMULSIONS;
GERMANY;
HOSPITALIZATION;
HUMAN;
KIDNEY TRANSPLANTATION;
SURVIVAL ANALYSIS;
TACROLIMUS;
HUMANS;
|
EID: 0036691911
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02964-0 Document Type: Conference Paper |
Times cited : (13)
|
References (8)
|